MARKET

BNGOW

Bionano Genomics
BNGOW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-5.4540
0.0038
0.0006
-
BIONANO GENOMICS INC - DIAGENS RECEIVED CLASS I REGISTRATION AND APPROVAL FOR CO'S OGM REAGENTS FROM CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Reuters · 04/17 12:01
BIONANO ANNOUNCES $10 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Reuters · 04/04 17:44
BIONANO ANNOUNCES 9 POSTER PRESENTATIONS AND INTRODUCES NEW HIGH THROUGHPUT STRATYS™ SYSTEM AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING
Reuters · 04/02 12:00
Bionano Genomics: Current report
Press release · 08/14/2023 15:01
Bionano Genomics: Current report
Press release · 08/09/2023 21:06
Bionano Genomics: Quarterly report
Press release · 08/09/2023 21:06
Bionano Genomics Inc reports results for the quarter ended in June - Earnings Summary
Reuters · 08/09/2023 21:03
Bionano Genomics Inc expected to post a loss of $1.03 a share - Earnings Preview
Reuters · 08/08/2023 02:05
More

Webull offers Bionano Genomics stock information, including NASDAQ: BNGOW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNGOW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNGOW stock methods without spending real money on the virtual paper trading platform.